Chris Abell

21.2k total citations · 4 hit papers
341 papers, 16.9k citations indexed

About

Chris Abell is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Chris Abell has authored 341 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Molecular Biology, 76 papers in Biomedical Engineering and 72 papers in Materials Chemistry. Recurrent topics in Chris Abell's work include Enzyme Structure and Function (51 papers), Innovative Microfluidic and Catalytic Techniques Innovation (51 papers) and Biochemical and Molecular Research (49 papers). Chris Abell is often cited by papers focused on Enzyme Structure and Function (51 papers), Innovative Microfluidic and Catalytic Techniques Innovation (51 papers) and Biochemical and Molecular Research (49 papers). Chris Abell collaborates with scholars based in United Kingdom, United States and South Sudan. Chris Abell's co-authors include Wilhelm T. S. Huck, Florian Hollfelder, Duncan E. Scott, Tom L. Blundell, Oren A. Scherman, Alison G. Smith, Ziyi Yu, Alessio Ciulli, Dejian Zhou and Martin Fischlechner and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Chris Abell

337 papers receiving 16.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microdroplets in Microfluidics: An Evolving Platform for Discoveries in Chemistry and Biology

2010 886 citations Chris Abell et al. Angewandte Chemie International Edition profile →
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

2016 802 citations Chris Abell et al. profile →
Kinematical studies of the flows around free or surface-mounted obstacles; applying topology to flow visualization

1978 544 citations Chris Abell et al. profile →
Tough Supramolecular Polymer Networks with Extreme Stretchability and Fast Room‐Temperature Self‐Healing

2017 436 citations Ji Liu, Cindy Soo Yun Tan et al. profile →

Peers

Countries citing papers authored by Chris Abell

Since Specialization

Citations

This map shows the geographic impact of Chris Abell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Abell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Abell more than expected).

Fields of papers citing papers by Chris Abell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Abell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Abell. The network helps show where Chris Abell may publish in the future.

Co-authorship network of co-authors of Chris Abell

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Abell. A scholar is included among the top collaborators of Chris Abell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Abell. Chris Abell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fragment-Based Development of Small Molecule Inhibitors Targeting Mycobacterium tuberculosis Cholesterol Metabolism 2025 ·Journal of Medicinal Chemistry ·Madeline E. Kavanagh, Kirsty J. McLean, (unknown), (unknown), M. Snee, Richard B. Tunnicliffe, Kriti Arora, Helena I. Boshoff, Alexander Fanourakis, María José Rebollo-López, Fátima Ortega, Colin Levy, Andrew W. Munro, David Leys, Chris Abell, Anthony G. Coyne	0
2	A Fragment‐Based Competitive ¹⁹F LB‐NMR Platform For Hotspot‐Directed Ligand Profiling 2024 ·Angewandte Chemie International Edition ·William J. McCarthy, S.E. Thomas, (unknown), (unknown), R. Andres Floto, Glyn Williams, Tom L. Blundell, Anthony G. Coyne, Chris Abell	0
3	A Fragment‐Based Competitive ¹⁹F LB‐NMR Platform For Hotspot‐Directed Ligand Profiling 2024 ·Angewandte Chemie ·William J. McCarthy, S.E. Thomas, (unknown), (unknown), R. Andres Floto, Glyn Williams, Tom L. Blundell, Anthony G. Coyne, Chris Abell	1
4	Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference** 2023 ·Angewandte Chemie International Edition ·Jamal El Bakali, M. Błaszczyk, Joanna C. Evans, (unknown), William J. McCarthy, (unknown), M.V.B. Dias, Eachan O. Johnson, Anthony G. Coyne, Valerie Mizrahi, Tom L. Blundell, Chris Abell, Christina Spry	8
5	Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference** 2023 ·Angewandte Chemie ·Jamal El Bakali, M. Błaszczyk, Joanna C. Evans, (unknown), William J. McCarthy, (unknown), M.V.B. Dias, Eachan O. Johnson, Anthony G. Coyne, Valerie Mizrahi, Tom L. Blundell, Chris Abell, Christina Spry	1
6	Fragment‐Merging Strategies with Known Pyrimidine Scaffolds Targeting Dihydrofolate Reductase from Mycobacterium tuberculosis 2023 ·ChemMedChem ·(unknown), (unknown), (unknown), (unknown), Chris Abell, Manuela Tosin, Anthony G. Coyne, M.V.B. Dias	1
7	Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach 2022 ·ACS Infectious Diseases ·Sitthivut Charoensutthivarakul, S.E. Thomas, (unknown), Karen Brown, Juan M. Belardinelli, Andrew Whitehouse, (unknown), (unknown), (unknown), Mary Jackson, V. Mendes, R. Andres Floto, Tom L. Blundell, Anthony G. Coyne, Chris Abell	10
8	A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen) 2022 ·European Journal of Medicinal Chemistry ·Martyn Frederickson, (unknown), Dimitrios Evangelopoulos, Kirsty J. McLean, (unknown), Richard B. Tunnicliffe, (unknown), Madeline E. Kavanagh, Sitthivut Charoensutthivarakul, Richard T. Blankley, Colin Levy, Luiz Pedro S. de Carvalho, David Leys, Andrew W. Munro, Anthony G. Coyne, Chris Abell	5
9	Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity 2021 ·ACS Infectious Diseases ·Joanna C. Evans, (unknown), John Post, V. Mendes, Zhe Wang, Navid Nahiyaan, (unknown), Stephen Thompson, Simon R. Green, Peter C. Ray, Jeannine Hess, Christina Spry, Anthony G. Coyne, Chris Abell, Helena I. Boshoff, Paul G. Wyatt, Kyu Y. Rhee, Tom L. Blundell, Clifton E. Barry, Valerie Mizrahi	6
10	Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification 2020 ·Nucleic Acids Research ·S.E. Thomas, Andrew Whitehouse, Karen Brown, Sophie Burbaud, Juan M. Belardinelli, (unknown), Ramanuj Lahiri, M. Daben J. Libardo, Pooja Gupta, Sony Malhotra, Helena I. Boshoff, Mary Jackson, Chris Abell, Anthony G. Coyne, Tom L. Blundell, R. Andres Floto, V. Mendes	18
11	Bioinspired hydrogel microfibres colour-encoded with colloidal crystals 2019 ·Materials Horizons ·Zhi‐Jun Meng, Jing Zhang, Xu Deng, Ji Liu, Ziyi Yu, Chris Abell	24
12	Development of Inhibitors against Mycobacterium abscessus tRNA (m ¹ G37) Methyltransferase (TrmD) Using Fragment-Based Approaches 2019 ·Journal of Medicinal Chemistry ·Andrew Whitehouse, S.E. Thomas, Karen Brown, Alexander Fanourakis, Daniel Shiu‐Hin Chan, M. Daben J. Libardo, V. Mendes, Helena I. Boshoff, R. Andres Floto, Chris Abell, Tom L. Blundell, Anthony G. Coyne	33
13	Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding Mode 2019 ·Journal of Medicinal Chemistry ·Andrew Whitehouse, M. Daben J. Libardo, Monica Kasbekar, P. Brear, Gerhard W. Fischer, Craig J. Thomas, Clifton E. Barry, Helena I. Boshoff, Anthony G. Coyne, Chris Abell	7
14	2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action 2019 ·Journal of Medicinal Chemistry ·(unknown), Irina Kufareva, Wei-Guang Seetoh, Chris Abell, Rolf W. Hartmann, Ruben Abagyan, Marc Le Borgne, Odile Filhol, Claude Cochet, Thierry Lomberget, Matthias Engel	20
15	2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site 2019 ·Journal of Medicinal Chemistry ·(unknown), Isabelle Krimm, Irina Kufareva, (unknown), Wei-Guang Seetoh, Chris Abell, Rolf W. Hartmann, Ruben Abagyan, Claude Cochet, Marc Le Borgne, Matthias Engel, Thierry Lomberget	27
16	Droplet microfluidics for the highly controlled synthesis of branched gold nanoparticles 2018 ·Scientific Reports ·Sara Abalde‐Cela, Patricia Taladriz‐Blanco, Marcelo G. de Oliveira, Chris Abell	122
17	Cucurbit[7]uril-based high-performance catalytic microreactors 2018 ·Nanoscale ·Xiaohe Ren, Ziyi Yu, Yuchao Wu, Ji Liu, Chris Abell, Oren A. Scherman	6
18	Supramolecular Nested Microbeads as Building Blocks for Macroscopic Self‐Healing Scaffolds 2018 ·Angewandte Chemie International Edition ·Ziyi Yu, Ji Liu, Cindy Soo Yun Tan, Oren A. Scherman, Chris Abell	49
19	Effect of DMSO on Protein Structure and Interactions Assessed by Collision-Induced Dissociation and Unfolding 2017 ·Analytical Chemistry ·(unknown), Madeline E. Kavanagh, Kirsty J. McLean, Andrew W. Munro, Dijana Matak‐Vinković, Anthony G. Coyne, Chris Abell	48
20	Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery 2013 ·Proceedings of the National Academy of Sciences ·H.L. Silvestre, T.L. Blundell, Chris Abell, Alessio Ciulli	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact